| Model Name | Description |
| T24/83 | T24/83 is a human bladder cancer xenograft model used to study high-grade transitional cell carcinoma and evaluate antitumor therapies. |
| RT112/84 | The RT112/84 xenograft model is derived from human bladder transitional cell carcinoma and is used to evaluate FGFR3-targeted therapies in vivo. |
| UM-UC-3 | The UM-UC-3 xenograft model is derived from human bladder carcinoma and is widely used to study aggressive, muscle-invasive bladder cancer and test anticancer therapeutics. |
| J82 | The J82 xenograft model is derived from human high-grade bladder carcinoma and is used to evaluate therapies targeting advanced, poorly differentiated bladder cancer. |
| HT1197 | The HT1197 xenograft model is derived from human bladder carcinoma and is used in preclinical studies to evaluate therapies targeting invasive, drug-resistant bladder cancer. |
| HT1376 | The HT1376 xenograft model is derived from human grade III bladder carcinoma and is used to assess therapies targeting invasive and poorly differentiated bladder tumors. |
| 5637 | The 5637 xenograft model is derived from human bladder carcinoma and is used to study early-stage, high-grade bladder cancer and evaluate potential therapeutic agents. |
| KMBC-2 | The KMBC-2 xenograft model is derived from human bladder carcinoma and is used to evaluate therapies for muscle-invasive bladder cancer. |
| SCaBER | The SCaBER xenograft model is derived from human squamous cell bladder carcinoma and is used to study aggressive bladder cancer and test therapeutic responses. |
| RT-4 | The RT-4 xenograft model is derived from human low-grade bladder transitional cell carcinoma and is used to study early-stage, non-invasive bladder cancer. |